Patent Number: 8,871,264

Title: Immediate release tablet formulations

Abstract: The present invention provides an immediate release pharmaceutical formulation which includes a tablet or capsule formulation comprising metformin and the sodium dependent glucose transporter (SGLT2) inhibitor dapagliflozin or its propylene glycol hydrate. The present invention also provides methods of preparing the formulations and methods of treating diseases or disorders associated with SGLT2 activity employing these formulations.

Inventors: Hallgren; Agneta (Molndal, SE), Swenson; Ralf Magnus Werner (Molndal, SE)

Assignee: AstraZeneca AB

International Classification: A61K 9/20 (20060101); A61K 9/28 (20060101); A61K 9/30 (20060101); A61K 31/70 (20060101); A61K 31/155 (20060101)

Expiration Date: 2018-10-28 0:00:00